Loop Health
+11%
est. 2Y upside i
Modern & comprehensive health insurance plan for employees in India
Rank
#1808
Sector
HealthTech
Est. Liquidity
~5Y
Data Quality
Data: MediumLoop Health offers moderate upside potential over 2 years (expected ~11%), but with significant risk due to stale valuation and lack of near-term liquidity.
Last updated: July 19, 2026
In a favorable IPO window, Loop Health maintains its 3.5x multiple on projected 2027 revenue of $121M, driven by category leadership in integrated health assurance. Entry valuation $235.8M yields 80% gross upside, net of 20% dilution gives 60% net upside.
Multiple converges to public comp range of 2.5x on $121M revenue, yielding $303M exit. After 20% dilution, upside is 8.5%.
Multiple compresses to 1.5x due to competitive pressure and slower growth, exit value $182M. Combined with 20% dilution, net downside of -42.9%.
Preference Stack Risk
moderateFunding Intensity
17%Total preferred stock of $40M represents 17% of current valuation, creating a moderate preference overhang for common shareholders.
Dilution Risk
highWith no funding since 2022 and a burn rate implied by 818 employees, a down round or significant dilution is likely, reducing upside by an estimated 20%.
Secondary Liquidity
noneNo secondary market activity is indicated.
Questions to Ask at the Interview
Strategic questions based on Loop Health's data — designed to show you've done your homework.
- 1
“How does Loop plan to achieve profitability given its high employee count (818) and revenue model?”
- 2
“What is the company's strategy to compete with traditional insurance brokers and large incumbents like ICICI Prudential?”
- 3
“Given the absence of a secondary market, what is the expected timeline for an IPO or acquisition?”
Community
Valuation Sentiment
Our model estimates +11% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.